Market overview

D-Allulose (D-psicose) is a rare sugar, a C-3 epimer of fructose that tastes like sugar but adds almost no calories. Food makers use allulose to cut sugar in beverages, confectionery, bakery, dairy and diabetic-friendly foods. Supply depends on enzymatic conversion of fructose, and market access depends on country-by-country food approvals and how labels treat the sugar.

The question this report answers
How large is the allulose sweetener market, which regulatory approvals open new demand, and which producers are positioned to supply it to 2035?

1. Demand: who uses allulose and where it is growing

Beverages are the largest single use and North America is the largest region (QYResearch; Fortune Business Insights).

Demand by application (share of 2025 consumption)
– Beverages (soft drinks, RTD tea and coffee, sports drinks): 38% (Market Krystal estimate)
– Bakery: 16% (Fortune Business Insights)
– Confectionery: 13% (Fortune Business Insights)
– Pharmaceuticals, nutrition and other uses: 10% (Market Krystal estimate)
– Dairy and frozen desserts: 9% (Fortune Business Insights)
– Other foods (tabletop, syrups, sauces, diabetic and keto foods): 14% (Market Krystal estimate)
Bakery, confectionery and dairy shares use Fortune Business Insights' 2025 food sub-segment values; beverages is a Market Krystal estimate anchored on QYResearch's 41% drinks share, and the remainder is allocated to tabletop, diabetic foods and pharmaceutical uses.

Demand by region (share of 2025 consumption)
– North America: 46% (Fortune Business Insights)
– Asia Pacific: 38% (Fortune Business Insights)
– Europe: 10% (Fortune Business Insights)
– South America: 4% (Fortune Business Insights)
– Middle East and Africa: 2% (Fortune Business Insights)

Where demand grows fastest to 2035
– Beverages: Beverages are forecast as the fastest-growing application at 11.46% CAGR to 2034 (Fortune Business Insights)
– China food and beverage: China approved allulose as a new food raw material in July 2025, opening sugar-free drinks, bakery and dairy to domestic supply (China NHC) (China National Health Commission)
– Liquid allulose for syrups and drinks: Liquid is the fastest-growing form at 11.35% CAGR to 2034 (Fortune Business Insights)

2. Supply: who makes allulose and how much

Samyang, Tate & Lyle, Matsutani with Ingredion, and Chinese producers such as Bailong Chuangyuan lead supply. Samyang alone runs 13,000 t/yr of allulose capacity in Ulsan (Samyang), and Chinese producers have added several 10,000 t-class lines since China's 2025 approval (Bailong Chuangyuan); total capacity exceeds current demand.

Main producers and capacity
– Samyang Corporation (South Korea): 13,000 t/yr allulose, Ulsan specialty plant (2024) (Samyang)
– Tate & Lyle (United Kingdom / United States): DOLCIA PRIMA crystalline and syrup allulose; sold in US, Mexico, Colombia, Chile
– Matsutani Chemical Industry (Japan): ASTRAEA allulose; owns approved D-allulose 3-epimerase enzyme in Japan and Korea (Matsutani / Japan Consumer Affairs Agency)
– Ingredion (Mexico): Allulose plant at San Juan del Rio, Mexico, under Matsutani licence (2019)
– Shandong Bailong Chuangyuan Biotechnology (China / Thailand): Crystalline allulose in Shandong; Thailand project adds crystalline allulose capacity (Bailong Chuangyuan)
– Bonumose (United States): USD 27.7 mn rare-sugar plant, Albemarle County, Virginia (The Hershey Company)

Production by region (share of 2025 output, Market Krystal analysis)
– China: 45%
– South Korea: 25%
– North America (US and Mexico): 20%
– Japan and rest of world: 10%

Trade and supply-demand balance
Korea and China export allulose to North America, which is the largest consuming region but has limited domestic output beyond Ingredion's Mexico plant and Bonumose (Samyang; Fortune Business Insights); global supply is in surplus.

3. Value chain: from feedstock to end market

Fructose (from corn starch or sucrose) + D-psicose 3-epimerase enzyme + Starch or maltodextrin → allulose → Beverages (soft drinks, RTD tea and coffee, sports drinks), Bakery, Confectionery

Raw materials
– Fructose (from corn starch or sucrose): Main substrate for enzymatic epimerisation and the largest variable cost (Samyang / FSANZ)
– D-psicose 3-epimerase enzyme: Strain and enzyme approvals decide market access in Japan, Korea and China (Japan Consumer Affairs Agency / MFDS / China NHC)
– Starch or maltodextrin: Feedstock for Bonumose's multi-enzyme cascade route (Bonumose)

Production route
Most allulose is made by enzymatic epimerisation of fructose with D-psicose 3-epimerase, then decolourised, separated by chromatography and crystallised; China also permits E. coli fermentation from glucose or sucrose (China NHC).

Downstream
Producers sell crystalline and liquid allulose to beverage bottlers, confectioners, bakers, dairy processors and tabletop brands, often blended with stevia or monk fruit.

Price, cost and margin
Allulose sells at a premium to sucrose; margin sits with producers that own efficient epimerase enzymes and crystallisation. Allulose trades at a premium to sucrose because conversion is incomplete and separation and crystallisation are energy-intensive (Market Krystal estimate). Margin sits with producers that own high-yield enzymes and crystalline capacity.

Where the chain is tightest
Enzyme and strain approvals are the tightest step, since each market approves specific epimerase preparations, as Korea will enforce from October 2026 (MFDS).

Who sits where in the chain
– Producer: Samyang Corporation, CJ CheilJedang, Ingredion, Shandong Bailong Chuangyuan, Daesang
– Producer and formulator: Tate & Lyle
– Enzyme and producer: Matsutani Chemical Industry
– Technology and producer: Bonumose
– End user: The Hershey Company
– Distributor: 1-2-Taste

4. Market size: what demand, supply and price add up to

Market Krystal preliminary estimate (2025)
Four publishers place the market at USD 148-204 mn for 2024-2025 (Global Market Insights, 360iResearch, Fortune Business Insights, QYResearch). Forecast growth ranges from about 8% to 18% a year. The range brackets the four 2024-2025 published estimates and rolls the 2024 figures forward one year. It is checked against announced capacity, including Samyang's 13,000 t/yr Ulsan line (Samyang), which shows global capacity well above current consumption; the check is indicative because no recognised price series exists. On this basis we use USD 160-220 mn. Confidence grade B: published estimates exist; the volume or price cross-check is partial.

How published estimates compare
Publishers agree on a 2024-2025 base of about USD 150-200 mn but differ widely on growth, from about 8% to 18% a year. Grand View's 2030 forecast sits above the others. Market Krystal sets its range from the clustered base and checks it against announced plant capacity and regulatory market access by country.

Key figures at a glance (third-party, cited)
– Global allulose market USD 147.7 mn in 2024, rising to USD 552.5 mn by 2034 (Global Market Insights)
– Global allulose market USD 201.03 mn in 2025; North America 46.28% share (Fortune Business Insights)
– Drinks hold 41% of allulose demand and North America 78% of the market (QYResearch)
– Samyang's Ulsan plant has 13,000 t/yr allulose capacity, more than four times its previous level, after a KRW 140 bn investment (Samyang)
– FDA lets allulose be excluded from total and added sugars and counted at 0.4 kcal/g (US FDA)

5. Outlook to 2035 and scenarios to 2047

Regulation and substitution
US label relief drives demand; EU approval is stalled, China opened in 2025 and Korea tightens enzyme rules from October 2026.

Recent developments among key stakeholders
– Oct 2026: Korea allows only allulose made with MFDS-certified epimerase enzymes to be imported or used, under MFDS Announcement No. 2025-403 (MFDS)
– Apr 2026: Bailong Chuangyuan reported that its Thailand project will add crystalline allulose capacity (Bailong Chuangyuan)
– Jul 2025: China approved D-allulose as a new food raw material, with intake up to 20 g/day and warnings for infants and pregnant or lactating women (China NHC)
– Jun 2025: EFSA concluded the safety of D-allulose as a novel food cannot be established because the applicant did not supply requested data (EFSA)
– Sep 2024: Samyang opened its Ulsan specialty plant with 13,000 t/yr of allulose capacity (Samyang)
– Aug 2024: FSANZ approved Samyang's D-allulose as a novel food for Australia and New Zealand (FSANZ)

What this means for the market
US beverage and snack brands remain the core buyers, and Korean and Chinese suppliers compete for them on price. China's 2025 approval creates a second large home market but also a capacity wave that may pressure prices from 2027. European food makers cannot use allulose until a new novel food dossier succeeds. Exporters to Korea must hold MFDS-certified enzymes from October 2026.

Strategic scenarios to 2047
– Base: US demand grows steadily, China and Asia Pacific add volume after the 2025 approval, and the EU opens late in the 2030s; allulose becomes a mainstream bulk sweetener alongside erythritol.
– Constrained supply: Stricter enzyme approvals in Korea and elsewhere, or US tariffs on Asian imports, limit qualified supply and keep prices high in North America.
– Technology transition: Low-cost routes from starch, such as Bonumose's enzyme cascade, and higher-yield epimerases cut cost toward sugar parity and open bulk soft-drink use.
The swing factor for allulose is EU novel food approval and the US added-sugars rule. Signposts: new EFSA dossier, FDA rulemaking on sugars metabolised differently, China capacity utilisation, Korea MFDS enzyme list, US import tariffs, beverage launches with allulose.

What this report delivers
Annual volume (tonnes) and value (USD) for 2026-2035, segmented by application: Beverages, Confectionery, Bakery, Dairy and frozen desserts, Tabletop and syrups, Diabetic and keto foods, Pharmaceuticals and nutrition; end use: Carbonated soft drinks, RTD tea and coffee, Chocolate and gummies, Cookies and cakes, Ice cream and yogurt, Sugar-free tabletop sweeteners; region: North America, Asia Pacific, China, South Korea, Japan, Europe, Latin America, India, Middle East and Africa. Each segment is backed by a producer capacity map, trade data and the Market Krystal estimate log, with scenarios to 2047 and strategic recommendations.